15
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Dermal Absorption and Tissue Disposition of 3,3′,14,4′-Tetrachloro biphenyl (TCB) in an Ex-vivo Pig Model: Assessing the Impact of Dermal Exposure Variables

Pages 127-137 | Published online: 19 Jul 2013

References

  • Hinz R, Lorence C, Hodson C, Hansch C, Hall L, Guy R. Percu-taneous penetration of para-substituted phenols in vitro. Fundam Appl Toxicol 1991; 17: 575–83.
  • World Health Organization. Environmental Health Criteria 140: Polychlorinated Biphenols and Terphenyls. 2nd ed. Geneva, Switzerland: WHO, 1993.
  • Wolff M. Occupational exposure to polychlorinated biphenyls (PCBs). Environ Health Perspect. 1985; 60: 133–8.
  • Safe S. Toxicology, structure-function relationship, and human and environmental health impacts of polychlorinated biphenyls: progress and problems. Environ Health Perspect. 1993; 100: 259–68.
  • De Vito M, Maier W, Diliberto J, Birnbaum L. Comparative ability of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4 weeks of treatment. Fundam Appl Toxicol. 1993; 20: 125–30.
  • Garner C, Jefferson W, Burka L, Matthews H, Newbold R. In vitro estrogencitiy of the catechol metabolites of selected polychlori-nated biphenyls. Toxicol Appl Pharmacol. 1999; 154: 188–97.
  • Jackson J, Diliberto J, Birnbaum L. Estimation of octanol-water partition coefficients and correlation with dermal absorption for several polyhalogenated aromatic hydrocarbons. Fundam Appl Toxicol. 1993; 21: 334–44.
  • Brown J Jr, Lawton R, Morgan C. PCB metabolism, persistence, and health effects after occupational exposure: implications for risk assessment. Chemosphere. 1994; 29: 2287–94.
  • Garner C, Matthews H. The effect of chlorine substitution on the dermal absorption of polychlorinated biphenyls. Toxicol Appl Pharmacol. 1998; 149: 150–8.
  • Wester R, Maibach H, Sedik L, Melendres J, Wade M. Percuta-neous absorption of PCBs from soil: in vivo rhesus monkey, in vitro human skin, and binding to powdered human stratum corneum. J Toxicol Environ Health. 1993; 39: 375–82.
  • Qiao G, Riviere J. Impacts of dermal model and exposure vari-ables on risk assessment of 3,3',4,4'-tetrachlorobiphenyl (TCB). Toxicol Sci. 1998; 42: 390.
  • Bandiera S, Safe S, Okey A. Binding of polychlorinated biphenyls classified as either phenobarbitone-, 3-methylcholanthrene- or mixed-type inducers to cytosolic Ah receptor. Chem Biol Interact. 1982; 39: 259–77.
  • Safe S. Polychlorinated biphenyls (PCBs): mutagenicity and car-cinogencity. Mutat Res. 1989; 220: 31–47.
  • Bartek M, Labudde J, Maibach H. Skin permeability in vivo: Com-parison in rat, rabbit, pig and man. J Invest Dermatol. 1972; 58: 114–23.
  • Qiao G, Chang S, Riviere J. Effects of anatomical site and occlu-sion on the percutaneous absorption and residue pattern of 2,6-[ring-14C] parathion in vivo pigs. Toxicol Appl Pharmacol. 1993; 122: 131–8.
  • Reifenrath W, Hawkins G. The weanling Yorkshire pig as an ani-mal model for measuring percutaneous penetration. In: Tumbel-son ME (ed). Swine in Biomedical Research. New York: Plenum, 1986: 673–80.
  • Monteiro-Riviere N, Stromberg M. Ultrastructure of the integu-ment of the domestic pig (Sus scrap) from one through fourteen weeks of age. Anat Histol Embryol. 1985; 14: 97–415.
  • Carver M, Riviere J. Percutaneous absorption and excretion of xenobiotics after topical and intravenous administration to pigs. Fundani Appl Toxicol. 1989; 13: 714–22.
  • Qiao G, Brooks J, Riviere J. Pentachlorophenol dermal absorp-tion and disposition from soil in swine: effects of occlusion and skin microorganism inhibition. Toxicol Appl Pharmacol. 1997; 147: 234–46.
  • Qiao G, Brooks J, Baynes R, Monteiro-Riviere N, Williams P, Riv-iere J. The use of mechanistically-defined chemical mixtures (MDCM) to assess mixture component effects on the percuta-neous absorption and cutaneous disposition of topically-exposed chemicals: I. Studies with parathion mixture in isolated perfused porcine skin. Toxicol Appl Pharmacol. 1996; 141: 473–86.
  • Reifenrath W, Chellquist E, Shipwash E, Jederberg W, Krueger G. Percutaneous penetration in the hairless dog, weanling pig and grafted athymic nude mouse: evaluation of models for predicting skin penetration in man. Br J Derrnatol. 1984; 3: 123–35.
  • Riviere J, Monteiro-Riviere N, Inman A. Determination of lido-caine concentration in skin after transdermal iontophoresis: ef-fects of vasoactive drugs. Pharmacol Res. 1992; 9: 211–4.
  • Riviere J, Bowman K, Monteiro-Riviere N, Dix L, Carver M. The isolated perfused porcine skin flap (IPPSF). I. A novel in vitro model for percutaneous absorption and cutaneous toxicology studies. Fundam Appl Toxicol. 1986; 7: 444–53.
  • Hughes M, Shrivastava S, Sumler M, et al. Dermal absorption of chemicals: effect of application of chemicals as a solid, aqueous paste, suspension, or in volatile vehicle. J Toxicol Environ Health. 1992; 37: 57–71.
  • Calabrese E. Principles of Animal Extrapolation. Chelsea, MI: Lewis Publications, 1991: 53-69.
  • Hansch C, Leo A, Hoekman D. Exploring QSAR: Hydrophonic Electronic and Steric Constants. Washington, DC: American Chemical Society, 1995: 348.
  • Bronaugh R, Stewart R, Storm J. Extent of cutaneous metabolism during percutaneous absorption of xenobiotics. Toxicol Appl Pharmacol. 1989; 99: 534–43.
  • Collier S, Sheikh N, Sakr A, Lichtin J, Stewart R, Bronaugh R. Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies. Toxicol Appl Pharmacol. 1989; 99: 522–33.
  • Bronaugh R, Stewart R, Congdon E, Giles, Riviere J, Inman A. Methods for in vitro percutaneous absorption studies. I. Comparison with in vivo results. Toxicol Appl Pharmacol. 1982; 62: 474–80.
  • Guy R, Hadgrafti Prediction of drug disposition kinetics in skin and plasma following topical administration. J Pharmacol Sci. 1984; 73: 883–7.
  • Hawkins G, Reifenrath W. Development of an in vitro model for determining the fate of chemicals applied to skin. Fundam Appl Toxicol. 1984; 4: S133–S144.
  • Franz T. Kinetics of cutaneous drug penetration. Ing Dermatol. 1983; 22: 499–505.
  • Surbe C, Wilhelm K, Hod M, Maibach H, Guy IL Optimization of topical therapy: partitioning of drug into stratum corneum. Phar-macol Res. 1990; 7: 1320–4.
  • Qiao G, Williams P, Riviere J. Percutaneous absorption, biotrans-formation and systemic disposition of parathion in vivo in swine. Comprehensive pharmacokinetic model. Drug Metab Dispos. 1994; 23: 459–71.
  • ikonaugh R, Barton C. Prediction of human percutaneous ab-sorption with physiocchemical data. In: Wang RCM (ed). Health Risk Assessment-Dermal and Inhalation Exposure and Absorp-tion of Toxicants. Boston, MA: CRC Press, 1993: 117-26.
  • Elias P. Advances in Lipid Research. Vol. 24: Skin Lipids. Orlando, FL: Academic Press, 1991.
  • Potts R, Francoeyr M. Physical methods for studying stratum corneum lipids (review). Semin Dermatol. 1992; 11: 129–38.
  • Potts R, Golden G, Franceour M, Mak V, Guy R. Mechanism and enhancement of solute transport across the stratum corneum. J Contr Rel. 1991; 15: 249–60.
  • Potts R, McNeill S, Desbournet C, Wakskull E. Transdermal drug transport and metabolism. II. The role of competing kinetic events. Pharmacol Res. 1989; 6: 119–26.
  • Surber C, Wilhelm K, Maibach H, Hall L, Guy R. Partitioning of chemicals into human stratum corneum: implications for risk as-sessment following dermal exposure. Fundam Appl Toxicol 1990; 15: 99–107.
  • Yoshikawa K, Adachi K, Halprin K, Levine V. Effects of short chain alcohols and hydrocarbon compounds on the adenylate cyclase of the skin. Br J Dermatol. 1976; 94: 611–4.
  • Man M, Feingold R, Elias P. Exogenous lipids influence perme-ability barrier recovery in acetone-treated murine skin. Arch Der-matol. 1993; 129: 728–38.
  • Wester R, Maibach H, Bucks D, et al. Percutaneous absorption and skin decontamination of PCBs: in vitro studies with human skin and in vivo studies in the rhesus monkey. J Toxicol Environ Health. 1990; 31: 235–46.
  • Williams P, Riviere J. A biophysically based dermatopharmacoki-netic compartment model for quantifying percutaneous penetra-tion and absorption of topically applied agent. I. Theory. J Phar-macol Sci. 1995;599–608.
  • Brooks J, Riviere J. Quantitative percutaneous absorption and cu-taneous distribution of binary mixtures of phenol and para-nitrophenol in isolated perfused porcine skin. Fundam Appl Tox-icol. 1996; 32: 233–43.
  • Qiao G, Brooks J, Inman A, et al. Dose formulation effects on an experimental model. Differences in dermal absorption and tissue disposition of pentachlorophenol (PCP): in vivo, ex vivo, and in vitro studies, Pharmacol Res. 1996; 13: 5417.
  • Moody R, Wester R, Melendres J, Maibach H. Dermal absorption of the phenoxy herbicide 2,4-D dimethylamine in humans: effect of DEFT and anatomic site. J Toxicol Environ Health. 1992; 36: 241–50.
  • World Health Organization. Chlorophenols other than pen-tachlorophenol. Geneva, Switzerland: WHO, 1989: 97-155.
  • Baynes R, Brownie C, Freeman H, Riviere J. In vitro percutaneous absorption of benzidine in complex mechanistically defined chemical mixtures. Toxicol Appl Pharmacol. 1996; 141: 497–506.
  • Bunge A Park J. Predicting dermal absorption from contact with chemically contaminated soils. In: Dwyer FJ, Doane TR, Hinman ML (eds). Environmental Toxicology and Risk Assessment: Mod-eling and Risk Assessment. 6th vol. Philadelphia, PA. ASTM STP 1317,1997: 227–44.
  • Qiao G, Riviere J. Significant effects of application site and occlu-sion on the pattern of cutaneous penetration and biotransforma-tion of Parathion in vivo in swine. J Pharmacol Sci. 1995; 84: 425–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.